Anti-adhesion clinical trial designs: Additional considerations

Research output: Contribution to journalArticle

Abstract

Study design is a crucial compound of the clinical trial. If a study is not well controlled or the appropriate study population is not chosen, it might not be possible to identify efficaciousness of an adjuvant for a reduction of postoperative adhesions. There is probably no one protocol that is most appropriate for all adjuvants; protocols must be individualized based on unique characteristics of the products and the manner in which they are to be used.

Original languageEnglish (US)
Pages (from-to)489-492
Number of pages4
JournalInfertility and Reproductive Medicine Clinics of North America
Volume14
Issue number3
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Clinical Trials
Population

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Anti-adhesion clinical trial designs : Additional considerations. / Diamond, Michael Peter.

In: Infertility and Reproductive Medicine Clinics of North America, Vol. 14, No. 3, 01.01.2003, p. 489-492.

Research output: Contribution to journalArticle

@article{2587be72bc5a44aa9db1a16b51ce20c6,
title = "Anti-adhesion clinical trial designs: Additional considerations",
abstract = "Study design is a crucial compound of the clinical trial. If a study is not well controlled or the appropriate study population is not chosen, it might not be possible to identify efficaciousness of an adjuvant for a reduction of postoperative adhesions. There is probably no one protocol that is most appropriate for all adjuvants; protocols must be individualized based on unique characteristics of the products and the manner in which they are to be used.",
author = "Diamond, {Michael Peter}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "14",
pages = "489--492",
journal = "Infertility and Reproductive Medicine Clinics of North America",
issn = "1047-9422",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Anti-adhesion clinical trial designs

T2 - Additional considerations

AU - Diamond, Michael Peter

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Study design is a crucial compound of the clinical trial. If a study is not well controlled or the appropriate study population is not chosen, it might not be possible to identify efficaciousness of an adjuvant for a reduction of postoperative adhesions. There is probably no one protocol that is most appropriate for all adjuvants; protocols must be individualized based on unique characteristics of the products and the manner in which they are to be used.

AB - Study design is a crucial compound of the clinical trial. If a study is not well controlled or the appropriate study population is not chosen, it might not be possible to identify efficaciousness of an adjuvant for a reduction of postoperative adhesions. There is probably no one protocol that is most appropriate for all adjuvants; protocols must be individualized based on unique characteristics of the products and the manner in which they are to be used.

UR - http://www.scopus.com/inward/record.url?scp=0041767992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041767992&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0041767992

VL - 14

SP - 489

EP - 492

JO - Infertility and Reproductive Medicine Clinics of North America

JF - Infertility and Reproductive Medicine Clinics of North America

SN - 1047-9422

IS - 3

ER -